Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Brummelen

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Clinical Pharmacology and Therapeutics|July 1, 1986
Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administrationC H Kleinbloesem, J van Harten, J P Wilson, et al.
Journal of Clinical Pharmacology|August 1, 1995
Pharmacokinetics and pharmacodynamics of Ro 41-3696, a novel nonbenzodiazepine hypnoticJ Dingemanse, M Bury, G Roncari, et al.
The Quarterly Journal of Medicine|March 1, 1988
Reconstructive surgery for renovascular hypertension. II. Influence of patient selection and anatomical result on the blood pressure response after operationJ H van Bockel, R van Schilfgaarde, W Felthuis, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 24, 1990
[Renal artery reconstruction for renovascular hypertension]J H van Bockel, R van Schilfgaarde, P van Brummelen, et al.
Clinical Pharmacology and Therapeutics|April 1, 1991
The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptorsG J Blauw, P van Brummelen, C J Doorenbos, et al.
Annals of the Rheumatic Diseases|July 1, 1990
Raised plasma renin and prorenin in rheumatoid vasculitisM Boers, F C Breedveld, B A Dijkmans, et al.
Clinical Pharmacology and Therapeutics|May 1, 1995
Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humansJ Dingemanse, K M Jorga, M Schmitt, et al.
Clinical and Experimental Hypertension|January 1, 1980
Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjectsF R Bühler, W Kiowski, P van Brummelen, et al.
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteersS Wijnands, P C Chang, G J Blauw, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 19, 1983
[Experiences with a rapid method for the determination of sodium chloride excretion in urine]M I Koolen, E A van der Velde, E Bussemaker-Verduyn den Boer, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|July 1, 1986
Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administrationC H Kleinbloesem, J van Harten, J P Wilson, et al.
Journal of Clinical Pharmacology|August 1, 1995
Pharmacokinetics and pharmacodynamics of Ro 41-3696, a novel nonbenzodiazepine hypnoticJ Dingemanse, M Bury, G Roncari, et al.
The Quarterly Journal of Medicine|March 1, 1988
Reconstructive surgery for renovascular hypertension. II. Influence of patient selection and anatomical result on the blood pressure response after operationJ H van Bockel, R van Schilfgaarde, W Felthuis, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 24, 1990
[Renal artery reconstruction for renovascular hypertension]J H van Bockel, R van Schilfgaarde, P van Brummelen, et al.
Clinical Pharmacology and Therapeutics|April 1, 1991
The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptorsG J Blauw, P van Brummelen, C J Doorenbos, et al.
Annals of the Rheumatic Diseases|July 1, 1990
Raised plasma renin and prorenin in rheumatoid vasculitisM Boers, F C Breedveld, B A Dijkmans, et al.
Clinical Pharmacology and Therapeutics|May 1, 1995
Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humansJ Dingemanse, K M Jorga, M Schmitt, et al.
Clinical and Experimental Hypertension|January 1, 1980
Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjectsF R Bühler, W Kiowski, P van Brummelen, et al.
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteersS Wijnands, P C Chang, G J Blauw, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 19, 1983
[Experiences with a rapid method for the determination of sodium chloride excretion in urine]M I Koolen, E A van der Velde, E Bussemaker-Verduyn den Boer, et al.
Pageof 16